Sanofi Beats GSK To Buy Merieux Alliance's Stake In India's Shantha Biotech; Move Aimed At Stronger Vaccines Business In Emerging Markets
This article was originally published in The Pink Sheet Daily
Executive Summary
Shantha's pipeline includes Rotavirus, conjugated typhoid and HPV vaccines.
You may also be interested in...
Emerging Markets, Acquisitions Prop Up Growth At Sanofi Aventis
Sanofi Aventis reported second quarter net sales up 6.5 percent at constant exchange rates, despite the early impact of generic competition in Europe on the heart drug Plavix (clopidogrel), anti-hypertensive Avapro (irbesartan), and cancer drug Eloxatin (oxaliplatin)
Emerging Markets, Acquisitions Prop Up Growth At Sanofi Aventis
Sanofi Aventis reported second quarter net sales up 6.5 percent at constant exchange rates, despite the early impact of generic competition in Europe on the heart drug Plavix (clopidogrel), anti-hypertensive Avapro (irbesartan), and cancer drug Eloxatin (oxaliplatin)
Emerging Markets, Acquisitions Prop Up Growth At Sanofi Aventis
CEO Viehbacher signals more acquisitions and radical changes in R&D as generics begin to bite into key brands including Plavix.